Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Serum and Synovial Uric Acid Validated as Markers for Osteoarthritis

By LabMedica International staff writers
Posted on 02 Feb 2011
The amount of uric acid in the synovial fluid of the knee is strongly correlated with the severity of osteoarthritis and the progression of the disease over time. More...


The amount of uric acid in both serum and synovial fluid can be estimated using high performance liquid chromatography (HPLC) and correlated with the severity of debilitating joint degeneration found in patients with osteoarthritis (OA).

A study carried out at Duke University Medical Center (Durham, NC, USA) examined 159 (118 females, 41 males) patients, who had knee osteoarthritis but no history of gout, a type of arthritis triggered by uric acid crystals in the joints. A total of 138 participants returned for follow-up three years later to assess progression of knee OA. The study was conducted from January 2003 until March 2008. Serum and knee synovial fluid samples were obtained within 10 minutes of each other after a two hour fast in the mid-afternoon. The synovial fluid analyses were limited to 69 study participants (49 women and 20 men) with sufficient synovial fluid volumes for uric acid analyses.

Although this cohort was recruited based on knee OA and absence of gout history, a surprising 39% of this cohort had serum uric acid concentrations above their respective reference ranges of 7.2 mg/dL for men and 6.0 mg/dL for women. Uric acid was quantified in both knees of 63 participants and single knees of 6 participants, and their paired sera. The mean serum uric acid concentrations were significantly higher than their paired synovial fluid uric acid concentrations. Of the 132 synovial fluid samples, matched serum exceeded synovial fluid uric acid concentrations for 113 (85.6%), whereas only 19 (14.4%) had greater synovial fluid than serum uric acid concentrations.

Virginia Byers Kraus, MD, PhD, professor of medicine at Duke University, said, "We've always thought of uric acid as the agent for gout, but it may be a much more general agent. In a non-gout population, this provides some of the very first evidence that uric acid level is a potential cause of inflammatory events and joint degeneration in osteoarthritis.” The study was accepted for publication on December 10, 2010, in the Proceeding of the [US] National Academy of Science of the United States, (PNAS).

Related Links:

Duke University Medical Center




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.